noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

Results

AGC Biologics Inc.

AGC Biologics Launches New Dedicated Cell and Gene Business Division

-3d
AGC Biologics Inc.

AGC Biologics Honored for Excellence in Contract Development and Manufacturing

3/10
AGC Biologics Inc.

AGC Biologics’ Milan Site to Prepare Lentiviral Vector Commercial Manufacturing for Adaptimmune’s Lete-Cel Product

1/16
AGC Biologics Inc.

Pandorum Partners with AGC Biologics to Support Clinical Manufacturing of Exosome-Based Kuragenx, a Treatment of Ulcerative Corneal Blindness

1/9
AGC Biologics Inc.

AGC Biologics Announces Leadership Updates Amid Groundbreaking of New Yokohama Site

-3m
AGC Biologics Inc.

New AGC Biologics CMC Jumpstart™ Program Offers Cell and Gene Developers Viral Vector Platform Assessments that Control Costs and Analyze Feasibility

-3m
AGC Biologics Inc.

AGC Biologics to Manufacture LVV for CAR-T Therapy Approved by FDA for Autolus Therapeutics’ AUCATZYL®

-3m
AGC Biologics Inc.

AGC Biologics Appoints Alberto Santagostino as new Chief Executive Officer

-5m
AGC Biologics Inc.

AGC Biologics Seattle Achieves Approval for all 2024 Biologics License Applications from U.S. Food and Drug Administration, Concluding Pre-License Inspection

-5m
AGC Biologics Inc.

AGC Biologics Begins Operations at New State of the Art Manufacturing Building in Copenhagen after Successful Inspection and Licensing from Danish Medicines Agency

-5m